Senators question Allergan CEO on tribe patent deal

A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.

Patent transfer to Mohawk tribe intended to stop generic drugs

Pharma Giant Allergan Fears Embrace Of Sanders's Medicare For All Plan

Allergan plc

Selling Sovereignty: How Corporations Used Tribal Sovereign Immunity to Evade Regulation and Exploit Consumers - The Flaw

Speaker Bios Do Not Delete - Foundry Events

Tangible IP's Latest IP Market Update

Trump's abandoned promise to bring down drug prices, explained - Vox

Patent Move Was 'Nuts,' Regeneron CEO Tells Allergan Chief - Bloomberg

Pharma Giant Allergan Fears Embrace Of Sanders's Medicare For All Plan

Allergan does patent deal for Restasis with Native American tribe

Ed Silverman - STAT - Page 218 of 299

Durotep MT, Radio Compass Blog, Latest Pharmaceutical Articles

Prescription Drug Costs

Senators blast Allergan's tribal deal, social contract as 'hypocrisy